Octanoic Acid
CAS 124-07-2
Octanoic Acid (CAS 124-07-2) is a Phase 2 pharmaceutical compound with 1 bioactivity target and 664 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 439.2857142857143 ug.mL-1 | 14 | - |
| - | Potency | 13638.8125 nM | 7 | - |
| - | Ki | 11203.333333333334 nM | 3 | - |
| - | EC50 | 100000 nM | 2 | - |
| - | IC50 | 19976.309999999998 nM | 1 | - |
| G-protein coupled receptor 84 GPCR |
Ki | 4.71 | - | Homo sapiens |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Caprylic Acid | 20178 | SU | MTHSPL |
| OCTANOIC ACID | 20178 | SU | MTHSPL |
| CAPRYLIC ACID | 20178 | SU | MTHSPL |
| octanoic acid | 20178 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Octanoic Acid used for in pharmaceutical contexts?
Octanoic Acid (CAS 124-07-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Octanoic Acid?
Octanoic Acid has 664 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Abdominal pain, Abdominal pain upper, Activated partial thromboplastin time prolonged, Anaemia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Octanoic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Caprylic Acid with EU status "permitted".
What clinical phase is Octanoic Acid in?
Octanoic Acid is rendered with ChEMBL max phase 2.
What bioactivity targets are documented for Octanoic Acid?
Octanoic Acid has 6 bioactivity rows in this page query. Rendered target entries include G-protein coupled receptor 84.